Coronavirus epidemic
On this page you will find information on the coronavirus and the epidemic from the perspective of the Wellbeing services county of Southwest Finland.
Management of the Wellbeing Services County
On this page, you can find the contact information on the management of the Wellbeing Services County of Southwest Finland.
Important phone numbers of the healthcare and social welfare services
In the wellbeing services county of Southwest Finland, the important and familiar appointment numbers and service numbers stay the same. On this website, you will find the most important phone numbers for the healthcare and social welfare services listed by municipality. The information…
The Wellbeing Services County of Southwest Finland
The Wellbeing Services County of Southwest Finland is the third largest wellbeing county in terms of population and second largest in terms of personnel.
Give feedback
Receiving feedback is important to us so that we can improve our care and operations.
Distribution of TYKS Foundation research grants to a new level in 2024
In 2024, the TYKS Foundation will allocate significantly more money to medical and health sciences research than before. This is enabled by significant donations received by the Foundation.
TYKS Foundation travel grants
TYKS Foundation has awarded the 2024 travel grants for researchers in medicine and health sciences. The €42,000 now awarded is part of the largest grant award in the foundation's history, totalling €300,000. The significantly higher award has been made possible by the significant donations…
More than one million donated to the TYKS Foundation
The TYKS Foundation has received a bequest of 1.6 million euros. The record-breaking donation is stated in the will of Jarmo Karppi (1953-2022) from Kaarina.
First Jarmo Karppi Award to Docent Päivi Lähteenmäki
The Jarmo Karppi Distinguished Cancer Researcher Award has been presented to Päivi Lähteenmäki, a specialist in paediatrics and paediatric haematology. She has made a particular contribution to the research and development of psychosocial support for people with childhood cancer…
The risk groups for preventive medication against RSV have been confirmed
In Finland, nirsevimab will be offered to all children born during the 2024-2025 winter RSV epidemic and to those under three months of age when the epidemic starts.
